Profile | GDS5420 / 228908_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 156.75 | 48 |
GSM1296119 | B_lesional_pre-dose | 222.98 | 54 |
GSM1296076 | C_lesional_pre-dose | 275.2 | 59 |
GSM1296092 | D_lesional_pre-dose | 318.78 | 61 |
GSM1296103 | E_lesional_pre-dose | 158.31 | 49 |
GSM1296078 | F_lesional_pre-dose | 134.19 | 48 |
GSM1296107 | G_lesional_pre-dose | 295.54 | 59 |
GSM1296109 | H_lesional_pre-dose | 196.41 | 51 |
GSM1296080 | I_lesional_pre-dose | 185.15 | 52 |
GSM1296090 | J_lesional_pre-dose | 342.24 | 62 |
GSM1296074 | K_lesional_pre-dose | 284.37 | 60 |
GSM1296111 | L_lesional_pre-dose | 228.51 | 54 |
GSM1296099 | M_lesional_pre-dose | 223.33 | 54 |
GSM1296086 | O_lesional_pre-dose | 263.5 | 58 |
GSM1296117 | P_lesional_pre-dose | 222.91 | 53 |
GSM1296113 | Q_lesional_pre-dose | 243.9 | 54 |
GSM1296096 | R_lesional_pre-dose | 262.22 | 57 |
GSM1296105 | S_lesional_pre-dose | 368.81 | 62 |
GSM1296098 | T_lesional_pre-dose | 310.66 | 59 |
GSM1296101 | U_lesional_pre-dose | 246.11 | 55 |
GSM1296121 | V_lesional_pre-dose | 142.86 | 46 |
GSM1296088 | W_lesional_pre-dose | 244.45 | 56 |
GSM1296082 | X_lesional_pre-dose | 172.44 | 52 |
GSM1296115 | Y_lesional_pre-dose | 150.77 | 47 |
GSM1296084 | Z_lesional_pre-dose | 285.63 | 58 |
GSM1296072 | B_lesional_day8 | 319.01 | 60 |
GSM1296069 | L_lesional_day8 | 202.73 | 51 |
GSM1296071 | P_lesional_day8 | 452.72 | 65 |
GSM1296070 | Y_lesional_day8 | 235.06 | 54 |
GSM1296073 | V_lesional_day8 | 126.16 | 45 |
GSM1296034 | A_lesional_day15 | 325.05 | 59 |
GSM1296041 | G_lesional_day15 | 252.9 | 56 |
GSM1296035 | R_lesional_day15 | 261 | 57 |
GSM1296038 | U_lesional_day15 | 199.97 | 52 |
GSM1296047 | B_lesional_day15 | 362.81 | 62 |
GSM1296039 | E_lesional_day15 | 235.34 | 55 |
GSM1296042 | H_lesional_day15 | 269.03 | 56 |
GSM1296043 | L_lesional_day15 | 262.59 | 55 |
GSM1296037 | M_lesional_day15 | 303.53 | 59 |
GSM1296046 | P_lesional_day15 | 332.76 | 60 |
GSM1296044 | Q_lesional_day15 | 362.81 | 61 |
GSM1296045 | Y_lesional_day15 | 279.85 | 57 |
GSM1296025 | C_lesional_day15 | 742.39 | 74 |
GSM1296033 | D_lesional_day15 | 385.92 | 63 |
GSM1296027 | I_lesional_day15 | 656.97 | 72 |
GSM1296032 | J_lesional_day15 | 536.85 | 68 |
GSM1296024 | K_lesional_day15 | 524.66 | 68 |
GSM1296031 | W_lesional_day15 | 430.03 | 65 |
GSM1296028 | X_lesional_day15 | 466.08 | 66 |
GSM1296029 | Z_lesional_day15 | 455.69 | 66 |
GSM1296026 | F_lesional_day15 | 189.96 | 52 |
GSM1296030 | O_lesional_day15 | 441.98 | 66 |
GSM1296040 | S_lesional_day15 | 212.33 | 53 |
GSM1296036 | T_lesional_day15 | 260.55 | 56 |
GSM1296048 | V_lesional_day15 | 222.37 | 54 |
GSM1296059 | A_lesional_day43 | 178.63 | 51 |
GSM1296066 | G_lesional_day43 | 288.65 | 58 |
GSM1296060 | R_lesional_day43 | 297.3 | 59 |
GSM1296063 | U_lesional_day43 | 250.23 | 56 |
GSM1296064 | E_lesional_day43 | 158.99 | 49 |
GSM1296067 | H_lesional_day43 | 438.45 | 65 |
GSM1296062 | M_lesional_day43 | 378.66 | 62 |
GSM1296068 | Q_lesional_day43 | 405.17 | 63 |
GSM1296050 | C_lesional_day43 | 605.6 | 71 |
GSM1296057 | D_lesional_day43 | 508.39 | 68 |
GSM1296052 | I_lesional_day43 | 569.81 | 70 |
GSM1296054 | J_lesional_day43 | 684.91 | 73 |
GSM1296049 | K_lesional_day43 | 603.23 | 71 |
GSM1296055 | W_lesional_day43 | 340.89 | 61 |
GSM1296053 | X_lesional_day43 | 514.52 | 68 |
GSM1296058 | Z_lesional_day43 | 294.24 | 59 |
GSM1296051 | F_lesional_day43 | 168.73 | 51 |
GSM1296056 | O_lesional_day43 | 208.47 | 54 |
GSM1296065 | S_lesional_day43 | 445.31 | 66 |
GSM1296061 | T_lesional_day43 | 528.8 | 68 |
GSM1296095 | A_non-lesional_pre-dose | 226.65 | 55 |
GSM1296120 | B_non-lesional_pre-dose | 253.78 | 55 |
GSM1296077 | C_non-lesional_pre-dose | 698.95 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 494.77 | 67 |
GSM1296104 | E_non-lesional_pre-dose | 254.56 | 56 |
GSM1296079 | F_non-lesional_pre-dose | 363.63 | 63 |
GSM1296108 | G_non-lesional_pre-dose | 398.96 | 64 |
GSM1296110 | H_non-lesional_pre-dose | 425.27 | 64 |
GSM1296081 | I_non-lesional_pre-dose | 493.57 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 424.58 | 65 |
GSM1296075 | K_non-lesional_pre-dose | 368.79 | 64 |
GSM1296112 | L_non-lesional_pre-dose | 293.43 | 57 |
GSM1296100 | M_non-lesional_pre-dose | 267.11 | 56 |
GSM1296087 | O_non-lesional_pre-dose | 645.16 | 72 |
GSM1296118 | P_non-lesional_pre-dose | 408.74 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 366.54 | 62 |
GSM1296097 | R_non-lesional_pre-dose | 284.93 | 58 |
GSM1296106 | S_non-lesional_pre-dose | 412.17 | 64 |
GSM1296102 | U_non-lesional_pre-dose | 350.07 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 322.86 | 60 |
GSM1296089 | W_non-lesional_pre-dose | 497.87 | 67 |
GSM1296083 | X_non-lesional_pre-dose | 253.74 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 297.74 | 58 |
GSM1296085 | Z_non-lesional_pre-dose | 437.78 | 65 |